Evidence map›Paper›PMID 33258531›Full record

Trial reportNeuromodulation : journal of the International Neuromodulation Society2021

To Trial or Not to Trial Before Spinal Cord Stimulation for Chronic Neuropathic Pain: The Patients' View From the TRIAL-STIM Randomized Controlled Trial.

Raymond Chadwick, Rebekah McNaughton, Sam Eldabe, Ganesan Baranidharan, Jill Bell, Morag Brookes, Rui V Duarte, Jenny Earle, Ashish Gulve, Rachel Houten and 8 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuromodulation : journal of the International Neuromodulation Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Spinal Cord Stimulation for Intractable Chronic Limb Ischemia: A Narrative Review.Journal of cardiovascular development and disease · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Raymond ChadwickDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.ORCID https://orcid.org/0000-0003-3034-5117
Rebekah McNaughtonSchool of Health and Social Care, Teesside University, Middlesbrough, UK.
Sam EldabeDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.ORCID https://orcid.org/0000-0002-9250-1886
Ganesan BaranidharanLeeds Neuromodulation Centre, Leeds Teaching Hospitals, Leeds, UK.ORCID https://orcid.org/0000-0002-1898-8243
Jill BellPatient and Public Involvement Representatives, Middlesbrough, UK.
Morag BrookesDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
Rui V DuarteLiverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.
Jenny EarlePatient and Public Involvement Representatives, Middlesbrough, UK.
Ashish GulveDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
Rachel HoutenLiverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.
Susan JowettHealth Economics Unit, University of Birmingham, Birmingham, UK.
Anu KansalDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
Shelley RhodesExeter Clinical Trials Unit, College of Medicine and Health, University of Exeter, Exeter, UK.
Jennifer RobinsonDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
Sara GriffithsDepartment of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
Rod S TaylorExeter Clinical Trials Unit, College of Medicine and Health, University of Exeter, Exeter, UK.
Simon ThomsonDepartment of Anaesthesia, Basildon and Thurrock University Hospitals, Basildon, UK.ORCID https://orcid.org/0000-0002-3027-9343
Harbinder SandhuWarwick Medical School, University of Warwick, Warwick, UK.
James Cook University Hospital · GBMiddlesbrough College · GBUniversity of Exeter · GBUniversity of Liverpool · GBBasildon and Thurrock University Hospitals NHS Foundation Trust · GBLeeds Teaching Hospitals NHS Trust · GBTeesside University · GBUniversity of Birmingham · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives Spinal cord stimulation (SCS) is an established treatment of chronic neuropathic pain. Although a temporary SCS screening trial is widely used to determine suitability for a permanent implant, its evidence base is limited. The recent TRIAL-STIM study (a randomized controlled trial at three centers in the United Kingdom) found no evidence that an SCS screening trial strategy provides superior patient outcomes as compared with a no trial approach. As part of the TRIAL-STIM study, we undertook a nested qualitative study to ascertain patients' preferences in relation to undergoing a screening trial or not. Materials and Methods We interviewed 31 patients sampled from all three centers and both study arms (screening trial/no trial) prior to SCS implantation, and 23 of these patients again following implantation (eight patients were lost to follow-up). Interviews were undertaken by telephone and audio-recorded, then transcripts were subject to thematic analysis. In addition, participants were asked to state their overall preference for a one-stage (no screening trial) versus two-stage (screening trial) implant procedure on a five-point Likert scale, before and after implantation. Results Emergent themes favoured the option for a one-stage SCS procedure. Themes identified include: saving time (off work, in hospital, attending appointments), avoiding the worry about having "loose wires" in the two-stage procedure, having only one period of recovery, and saving NHS resources. Participants' rated preferences show similar support for a one-stage procedure without a screening trial. Conclusions Our findings indicate an overwhelming preference among participants for a one-stage SCS procedure both before and after the implant, regardless of which procedure they had undergone. The qualitative study findings further support the TRIAL-STIM RCT results.

Indexed as

Chronic PainNeuralgiaSpinal Cord StimulationHumansPatient PreferenceSpinal CordTreatment OutcomeNeuropathic painpatient choicescreening trialspinal cord stimulationthematic analysis

Identifiers

PMID33258531
PMCPMC8246937
OpenAlexW3096738651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.